Get Your Glow On

Adults who are obese (BMI ≥30) or overweight (BMI ≥27) with weight-related medical problems (ie: high blood pressure, high cholesterol, Type 2 diabetes) to help them lose weight & maintain weight loss long-term. Please Book a Consultation with our provider to see if you are a candidate.

It works as an appetite suppressant by mimicking the hormone "glucagon-like peptide-1" (GLP-1), which targets areas of the brain that regulate appetite and food intake. It increases fullness, delays gastric emptying, and regulates blood sugar levels.

If individuals are safely receiving the medication in a medical weight loss clinic and follow their program's recommendations, we expect an average body weight reduction of 10%-15%. Please note: Individual results may vary and there are no guarantees for effectiveness or success of any medication. For published clinical studies showing efficacy and safety of a type of GLP-1 medication, Semaglutide, please click the following: Friedrichsen M, Breitschaft A, Tadayon S, Wizert A, Skovgaard D. The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity (2022, Oct). Diabetes Obes Metab. 2021 Mar;23(3):754-762. doi: 10.1111/dom.14280 Garvey, W.T., Batterham, R.L., Bhatta, M. et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nat Med 28, 2083–2091 (2022). https://doi.org/10.1038/s41591-022-02026-4 Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, Wharton S, Yokote K, Zeuthen N, Kushner RF; STEP 1 Study Group. Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021, Feb). N Engl J Med. 2021 Mar 18;384(11):989-1002. doi: 10.1056/NEJMoa2032183

NO. We prescribe compounded glucagon-like peptide-1 (GLP-1). We receive all our medications directly from FDA-regulated compounding pharmacies and manufacturing labs that adhere to strict cGMP guidelines and conducts third-party lab testing to ensure our medications are sterile, stable, potent, and safe for use.

It is a once-weekly injection under the skin (subcutaneous), typically in the stomach. Pain is usually minimal as the injection is quick and shallow. To ensure weight loss success, we have patients come in every week so we can monitor their weight progress, manage any side effects, and administer the medication in-office. We do NOT ship or send patients medication vials to draw and administer the medication at home.

It should absolutely not be used in patients who are pregnant, breastfeeding, have a personal or family history of medullary thyroid carcinoma, or have a rare condition called Multiple Endocrine Neoplasia syndrome type 2*. *FOR A FULL LIST OF CONTRAINDICATIONS, PLEASE CONSULT YOUR SHAPE & SKIN PROVIDER.